Envista Holdings Corp

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The firm operates through the following segments: Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018, and is headquartered in Brea, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Envista Holdings Corp posts robust 2022 results amidst market challenges

Envista Holdings Corp reported strong 2022 performance with core sales growth and expanded EBITDA margins. Despite Q4 challenges, the company remains optimistic about long-term growth prospects in the dental market. Envista's strategic focus on innovation, operational efficiency, and disciplined growth strategies underpin its commitment to achieving long-term targets and driving shareholder value.

Envista Holdings Corp reports Q1 challenges but sees growth opportunities

Envista Holdings Corp faces challenges in core sales and EBITDA margins in Q1 2023, with a focus on accelerating organic growth and improving the E&C business. Despite short-term uncertainties in China and Russia, the company sees opportunities in expanding margins and driving growth through strategic shifts.

Envista Holdings Corp reports solid Q2 performance amidst market challenges

Envista Holdings Corp (NVST) delivered a resilient performance in Q2 2023, showcasing strengths in core revenue growth, operational improvements, and cash flow generation. While facing challenges in certain segments and regions, the company remains optimistic about achieving its full-year guidance and capitalizing on growth opportunities through strategic initiatives.

Envista Holdings Corp reports positive Q3 performance amidst challenges

Envista Holdings Corp reported positive core growth and margin performance in Q3 2023.
Challenges in the implant business and distribution channels are being addressed through strategic investments.
The company is committed to balancing growth and margin expansion for long-term success.
Envista reaffirms its dedication to navigating challenges and driving future growth.

Envista Holdings Corp reports mixed 2023 performance, eyes growth opportunities

Envista Holdings Corp's 2023 performance showed mixed results with challenges in the global dental market and specific issues impacting segments like Equipment & Consumables. Despite these challenges, the company is focusing on optimizing operations, accelerating key businesses, and navigating short-term issues to drive long-term growth. Envista remains cautiously optimistic about 2024, expecting low single-digit core sales growth and improved margins.

Envista reports modest Q1 growth, eyes China for expansion

Envista Holdings Corp (NVST) reported modest Q1 growth, with a focus on accelerating orthodontic and implant businesses, driving operational improvements, and addressing market challenges.
The company is optimistic about its growth potential in China, aiming to close the gap in market growth in North America and reinvigorate growth in the region.
Envista's strategic investments, focus on cost optimization, and plans for talent acquisition position the company for long-term value creation and success in the industry.

Envista Holdings Corp reports Q2 challenges but sees growth opportunities

Envista Holdings Corp faced challenges with core sales decline and impairment charges but improved free cash flow significantly.
Despite the setbacks, the company made strategic investments and saw growth in active Spark doctors and international expansion.
Envista's focus on market conditions, new appointments, and expanding Spark presents opportunities for future growth and success.

Envista Holdings Corp reports mixed Q3 results, eyes margin improvement

Envista's Q3 performance reflects a mix of strengths and challenges, with opportunities for margin improvement and market expansion.
Strong free cash flow and growth in specific segments demonstrate operational resilience and strategic focus.
Management's optimism for future performance indicates confidence in the company's ability to navigate current market dynamics.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. It operates through Specialty Products and Technologies, and Equipment and Consumables segments. The Specialty Products and Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment and Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018, and is headquartered in Brea, CA.

BREA, Calif. , May 17, 2022  /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced it has entered into a definitive agreement to acquire Osteogenics Biomedical Inc, Allotech LLC and OBI Biologics, Inc (together "Osteogenics").

ENVISTA TO ACQUIRE OSTEOGENICS BIOMEDICAL BUSINESS

BREA, Calif. , May 16, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in William Blair Emerging Technologies in Dental Care Virtual Conference on Tuesday, May 17 th from 7:00 – 7:45 AM PT.

Envista Announces Participation in William Blair Emerging Technologies in Dental Care Virtual Conference

Envista Holdings Corp, Inc. (NYSE:NVST ) Q1 2022 Earnings Conference Call May 4, 2022 5:00 PM ET Company Participants Stephen Keller - Vice President, Investor Relations Amir Aghdaei - President, CEO & Director Howard Yu - Senior VP & CFO Conference Call Participants Jeffrey Johnson - Robert W. Baird & Co. Elizabeth Anderson - Evercore ISI Erin Wright - Morgan Stanley Nathan Rich - Goldman Sachs Group Michael Cherny - Bank of America Merrill Lynch Jason Bednar - Piper Sandler & Co. Jonathan Block - Stifel, Nicolaus & Company Operator My name is Chelsea, and I will be your conference call facilitator this afternoon.

Envista Holdings Corp (NVST) CEO Amir Aghdaei on Q1 2022 Results - Earnings Call Transcript

Envista (NVST) delivered earnings and revenue surprises of 6.82% and 0.77%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Envista (NVST) Q1 Earnings and Revenues Top Estimates

BREA, Calif. , May 4, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the first quarter 2022.

Envista Reports First Quarter 2022 Earnings

BREA, Calif., April 20, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced the completion of the acquisition of Carestream Dental's Intraoral Scanner business.

Envista Completes Acquisition of Carestream Dental's Intraoral Scanner Business

BREA, Calif. , April 13, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its first quarter 2022 on Wednesday, May 4, 2022.

Envista Schedules First Quarter 2022 Earnings Call

BREA, Calif. , March 29, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced Envista's KaVo imaging business will be re-branded as "DEXIS".

Envista Announces DEXIS Brand Name for Imaging Business

BREA, Calif. , March 28, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") -- Envista announced today the 510(k) Food and Drug Administration (FDA) clearance of its Assisted Intelligence (AI) mandibular nerve tracing feature in its image acquisition and diagnostic software platform DTX Studio Clinic.

Envista Obtains FDA Clearance for Assisted Intelligence Mandibular Nerve Tracing

BREA, Calif. , March 17, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in Piper Sandler Dental Day on Tuesday, March 29 th from 7:00 – 7:45 AM PT.

Envista Announces Participation in Piper Sandler

BREA, Calif., March 7, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced that the company will be holding an Investor Day at its Envista Summit on Friday, April 1 st from 8:00 am – 10:30 am CT.

Envista To Hold Investor Day at Envista Summit

BREA, Calif., Feb. 22, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in Jefferies Virtual Dental Summit on Thursday, February 24 th from 6:00 – 6:45 AM PST.

Envista Announces Participation in Jefferies Virtual Dental Summit

Ensign Group

Vir Biotechnology

Are these on your list of best health care stocks to buy right now?

Hot Stocks To Buy Right Now? 3 Health Care Stocks For Your Watchlist

Envista Holdings Corporation's (NVST) CEO Amir Aghdaei on Q4 2021 Results - Earnings Call Transcript

Envista (NVST) delivered earnings and revenue surprises of 9.52% and 2.94%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Envista (NVST) Beats Q4 Earnings and Revenue Estimates

BREA, Calif., Feb. 9, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the fourth quarter and fiscal year 2021.

Envista Reports Fourth Quarter 2021 Earnings

BREA, Calif., Feb. 7, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) announced that it has renewed its partnership agreement with the Vitaldent Group, a leading Spanish Dental Service Organization (DSO).

Envista Renews Commercial Partnership with Vitaldent Group

Envista (NVST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Envista (NVST) Could Beat Earnings Estimates Again

Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Envista (NVST) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

The stock price of Envista Holdings Corporation (NYSE: NVST) increased by 0.37% in the most recent trading session. This is why it happened.

Envista (NVST) Stock: Why The Price Went Up

BREA, Calif., Jan. 31, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") -- and leading dental support organization Pacific Dental Services® (PDS) announced today the extension of their implant and imaging commercial relationship for an additional five years, and the expansion of this relationship to include Envista's Spark clear aligners.

Envista and Pacific Dental Services Announce Extension of Implant, Imaging, and Clear Aligner Commercial Relationship

BREA, Calif., Jan. 19, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2021 on Wednesday, February 9, 2022.

Envista Schedules Fourth Quarter 2021 Earnings Call

BREA, Calif., Jan. 10, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") -- Envista and leading dental support organization Pacific Dental Services®  (PDS) announce today the consummation of a multi-year year development partnership, created to harness the power of Assisted Intelligence (AI) in support of clinical image analysis across the dental market.

Envista and Pacific Dental Services Announce Assisted Intelligence Development Partnership

BREA, Calif., Jan. 3, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that it closed the previously disclosed divestiture of its KaVo Treatment Unit & Instrument business.

Envista Closes Divestiture of KaVo Treatment Unit & Instrument Business

Envista (NVST) noted that the Nobel Biocare N1 system represents a significant step further in patient-centric dental implant solutions.

News for Envista Holdings Corp Stock (NVST)